Skip to content

HemoRea

Active
Private limited company·Activiteiten van medisch specialisten· 5 yrs active
Rue des Fougères(JB) 12 ·5100 Namur, Belgium
KBO/BCE: BE 0755.776.191
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age5 yrs
Board1
Real estate1 parcel · 853 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of HemoRea is 0.4% (very low). The 2021 annual accounts show equity of €30k and a net result of €8k. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 13 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-07-2025, 8 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 5 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 23-07-2025 8 d early 2025-00296483
31-12-2023 31-07-2024 23-07-2024 8 d early 2024-00272884
31-12-2022 31-07-2023 10-07-2023 21 d early 2023-00218158
31-12-2021 31-07-2022 16-08-2022 16 d late 2022-20289430
31-12-2020 31-07-2021 20-07-2021 11 d early 2021-37100026

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.4% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Young company +Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€8k-58.5%
Working capital€30k+33.4%

Annual accounts & ratios

Source: NBB · 2021
Annual accounts filed on 23-07-2025 with the NBB · fiscal year 2024 · micro
€0€10k€20k€30kOperating result 2020: €27k€27kNet result 2020: €20k€20kOperating result 2021: €12k€12kNet result 2021: €8k€8k20202021
Operating resultNet result
Net profit
€8k
-58.5% 20-21
Total assets
€41k
+37.0% 20-21
Equity
€30k
+33.4% 20-21
Working capital
€30k
+33.4% 20-21
Income taxes
€3k
-61.4% 20-21
Dividends
€800
- 20-21
Debt
€11k
+48.4% 20-21
Debt ≤ 1y
€11k
+48.4% 20-21
Current ratio
3.85
-7.7% 20-21
Quick ratio
3.85
-7.7% 20-21
Solvency
74.1%
-2.6% 20-21
Debt / equity
0.35
- 20-21
ROE
27.7%
-68.9% 20-21
ROA
20.5%
-69.7% 20-21
Figures by fiscal year
Fiscal year2021
Depositmicro
Revenue-
EBITDA-
Net profit€8k
Cash flow-
Staff costs-
Income taxes€3k
Dividends€800
Total assets€41k
Equity€30k
Debt€11k
of which ≤ 1y€11k
of which > 1y-
Working capital€30k
Employees (FTE)-
Ratios (computed)
2021
Current ratio3.85
Quick ratio3.85
Working capital ratio74.1%
Solvency74.1%
Debt / equity0.35
Long-term debt ratio-
Interest coverage-
Gross margin-
Net margin-
ROA20.5%
ROE27.7%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2021
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2021
Balance sheet, Assets
TOTAL ASSETS 20/58€41k
Current assets 29/58€41k
Amounts receivable within one year 40/41€3k
Cash & bank 54/58€38k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€41k
Equity 10/15€30k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€28k
Amounts payable 17/49€11k
Amounts payable within one year 42/48€11k
Income statement
Gross operating margin 9900€15k
Operating result 9901€12k
Financial charges 65€956
Result before taxes 9903€11k
Income taxes 67/77€3k
Net result for the period 9904€8k
Result to be appropriated 9905€8k
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2021 · computed
85 / 100 Excellent
050100
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2021. Indicative, not credit advice.

Directors

Directors & mandates

1 director
Current directors & mandates
  • Nathalie LAYIOS
    Director
    State Gazette act 25056714 (02-05-2025)
    Current
    01-01-2025 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Activiteiten van medisch specialisten(86220)
Legal form Private limited company(610)
Incorporation06-10-2020
StatusActive
Postal code5100

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
HemoRea SRL
Rue des Fougères(JB) 12, 5100 NamurActiviteiten van medisch specialisten
since 20202.308.450.639
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area853 m²
Buildings1
Building footprint108 m²
Volume (LiDAR)624 m³
Tallest building7.0 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92322D0366/00E003 Wallonia 852 m² 1 · 108 m² 7.0 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
All acts · 1 updated 1 year ago
2025
02-05-2025 Nathalie LAYIOS appointed as director Director changes·PGujnef
  • Nathalie LAYIOS, Bestuurder
Notary: PGujnef · Liège

Analysis

Snowflake analysis

financial profile on 5 axes
Health85Profitability100Solvency100Growth52Stability94
86 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 85
Profitability 100
Solvency 100
Growth 52
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector
We hold annual accounts for 1,978 of the 16,601 companies in this sector. 1,371 of them are within a factor 10 of this company's equity.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameFR HemoRea
Registered office
Rue des Fougères(JB) 12
5100 Namur, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.